ATE163547T1 - Stabilisierte impfstoffzusammensetzungen - Google Patents

Stabilisierte impfstoffzusammensetzungen

Info

Publication number
ATE163547T1
ATE163547T1 AT90913372T AT90913372T ATE163547T1 AT E163547 T1 ATE163547 T1 AT E163547T1 AT 90913372 T AT90913372 T AT 90913372T AT 90913372 T AT90913372 T AT 90913372T AT E163547 T1 ATE163547 T1 AT E163547T1
Authority
AT
Austria
Prior art keywords
vaccine compositions
stabilized vaccine
polyimines
stabilized
amino
Prior art date
Application number
AT90913372T
Other languages
English (en)
Inventor
Brent Dorval
Marie Chow
Alexander Klibanov
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE163547T1 publication Critical patent/ATE163547T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90913372T 1989-08-15 1990-08-14 Stabilisierte impfstoffzusammensetzungen ATE163547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39399689A 1989-08-15 1989-08-15

Publications (1)

Publication Number Publication Date
ATE163547T1 true ATE163547T1 (de) 1998-03-15

Family

ID=23557105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913372T ATE163547T1 (de) 1989-08-15 1990-08-14 Stabilisierte impfstoffzusammensetzungen

Country Status (9)

Country Link
US (1) US5618539A (de)
EP (1) EP0487632B1 (de)
JP (1) JP3064413B2 (de)
AT (1) ATE163547T1 (de)
CA (1) CA2065023A1 (de)
DE (1) DE69032102T2 (de)
DK (1) DK0487632T3 (de)
ES (1) ES2113348T3 (de)
WO (1) WO1991002543A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
AU2003225057A1 (en) * 2002-04-19 2003-11-03 The Regents Of The University Of Michigan Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
US20060110406A1 (en) * 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
KR101190932B1 (ko) * 2003-02-25 2012-10-16 메디뮨 엘엘씨 인플루엔자 백신 조성물의 제조 방법
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
BRPI0800357A2 (pt) * 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
AU2009295623A1 (en) * 2008-09-24 2010-04-01 Stabilitech Ltd Method for preserving polypeptides using a sugar and polyethyleneimine
US20110212127A1 (en) * 2008-09-24 2011-09-01 Stabilitech Ltd. Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
GB2499480A (en) 2010-03-31 2013-08-21 Stabilitech Ltd Method for preserving alum adjuvants and alum-adjuvanted vaccines
EP2552478B1 (de) 2010-03-31 2016-12-21 Stabilitech Ltd. Hilfsstoffe zur stabilisierung von viralen partikeln
JP5960120B2 (ja) 2010-03-31 2016-08-02 スタビリテック リミテッド ウイルス粒子の安定化
CN108588035A (zh) 2011-06-28 2018-09-28 白血球保健股份有限公司 病毒或细菌的新型稳定方法
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US9283270B2 (en) 2012-01-20 2016-03-15 Serum Institute Of India Ltd. Method for stabilization of biological molecules
TWI690322B (zh) * 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
CN105517568B (zh) * 2013-06-17 2020-07-07 由卫生福利和体育大臣代表的荷兰王国 防止病毒组分聚集的方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097142A (en) * 1960-03-30 1963-07-09 Merck & Co Inc Benzyl alcohol stabilized polio vaccines and production thereof
US3097143A (en) * 1960-03-30 1963-07-09 Merck & Co Inc Myristyl-gamma-picolinium chloride preserved polio vaccine and its production
US3128229A (en) * 1961-10-05 1964-04-07 Baylor Medical Foundation Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein
GB1564998A (en) * 1975-03-21 1980-04-16 Connaught Lab Vaccine and stabilizing solution therefor
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation

Also Published As

Publication number Publication date
DE69032102D1 (de) 1998-04-09
JP3064413B2 (ja) 2000-07-12
ES2113348T3 (es) 1998-05-01
DE69032102T2 (de) 1998-06-25
JPH04506973A (ja) 1992-12-03
EP0487632B1 (de) 1998-03-04
WO1991002543A1 (en) 1991-03-07
US5618539A (en) 1997-04-08
CA2065023A1 (en) 1991-02-16
DK0487632T3 (da) 1998-05-25
EP0487632A1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
ATE163547T1 (de) Stabilisierte impfstoffzusammensetzungen
DK0414263T3 (da) Fremgangsmåde til stabilisering af et fast farmaceutisk præparat indeholdende cycliske aminosyrer
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
PT99779A (pt) Processo para a preparacao de composicoes liquidas concentradas a base de sucralose
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ES8704931A1 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
BR9906927A (pt) Proteìnas de neisseria meningitidis
DK669088D0 (da) Fremgangsmaade og praeparat til forbedring af erkendelsesfunktionen
DE3876050D1 (de) Okulare hypotensivagenzien.
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
AU535183B2 (en) Triazine derivatives used as light stabilisers for organic polymers
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
ATE183747T1 (de) Halogen-freie, cyclische, phosphor enthaltende flammenhemmende verbindungen
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
EP0176106A3 (en) N,n',n-tris((2,2,6,6-tetramethyl-4-piperidyl)triazinyl)-undecane triamines as stabilizers for synthetic polymers
NO924774D0 (no) Karboksyvinylpolymer som har newtonsk viskositet
DK0487562T3 (da) Farmaceutiske sammensætninger
ATE165369T1 (de) Antikoagulierende peptide
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
IL86723A0 (en) Guanidine-related compounds comprising a tetraphenylborate ion,their preparation and their use
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
IT1235665B (it) Stabilizzatore aminico polimerico per spandex.
SE9402253D0 (sv) Process

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee